A Multicenter Phase Ii Trial of Nab-Paclitaxel in Combination with Capecitabine in Patients (Pts) with Her-2 Negative and Triple Negative Advanced Breast Cancer (Abc): an Interim Analysis

Annals of Oncology ◽

10.1093/annonc/mdu329.20 ◽

2014 ◽

Vol 25 ◽

pp. iv123

Author(s):

M. Ciccarese ◽

L. Orlando ◽

P. Fedele ◽

P. Schiavone ◽

E. Maiello ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Interim Analysis ◽

Triple Negative ◽

Phase Ii Trial ◽

Advanced Breast ◽

Multicenter Phase ◽

Her 2

Download Full-text

A multicenter phase II trial of nab‐paclitaxel and capecitabine in HER‐2 negative and triple‐ negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?

The Breast Journal ◽

10.1111/tbj.13856 ◽

2020 ◽

Vol 26 (9) ◽

pp. 1857-1859

Author(s):

Mariangela Ciccarese ◽

Laura Orlando ◽

Palma Fedele ◽

Paola Schiavone ◽

Evaristo Maiello ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Triple Negative ◽

Phase Ii Trial ◽

Advanced Breast ◽

Multicenter Phase ◽

Her 2

Download Full-text

SAKK 21/12: A stratified, multicenter phase II trial of transdermal CR1447 in endocrine responsive-HER2 negative and triple negative-androgen receptor positive metastatic or locally advanced breast cancer

Annals of Oncology ◽

10.1093/annonc/mdz100.014 ◽

2019 ◽

Vol 30 ◽

pp. iii52

Author(s):

M.H.F. Vetter ◽

K. Rothgiesser ◽

Q. Li ◽

H. Hawle ◽

W. Schönfeld ◽

...

Keyword(s):

Breast Cancer ◽

Androgen Receptor ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Triple Negative ◽

Phase Ii Trial ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Advanced Breast ◽

Multicenter Phase

Download Full-text

Multicenter phase II trial of gemcitabine plus liposomal doxorubicin in chemotherapeutically pretreated patients with advanced breast cancer (ABC

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.696 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 696-696

Author(s):

K. Haider ◽

G. Kornek ◽

W. Kwasny ◽

D. Depisch ◽

T. Payrits ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Advanced Breast ◽

Multicenter Phase ◽

Pretreated Patients

Download Full-text

Run-in-phase results from a multicenter phase II trial to evaluate pembrolizumab (P) and gemcitabine (Gem) in patients (pts) with HER2-negative advanced breast cancer (ABC): GEICAM/2015-04 PANGEA-Breast

Annals of Oncology ◽

10.1093/annonc/mdy487.019 ◽

2018 ◽

Vol 29 ◽

pp. x32

Author(s):

V. Quiroga ◽

E. Holgado ◽

J.L. Alonso ◽

R. Andres ◽

F. Moreno Anton ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Breast ◽

Multicenter Phase

Download Full-text

Preliminary results of a multicenter phase II trial of neoadjuvant docetaxel, carboplatin and capecitabine for inflammatory and locally advanced breast cancer (LABC)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.876 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 876-876 ◽

Cited By ~ 1

Author(s):

S. X. Franco ◽

A. Perez ◽

C. Frankel ◽

E. Tan-Chiu ◽

L. Schwartzberg ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Advanced Breast ◽

Preliminary Results ◽

Multicenter Phase

Download Full-text

A multicenter, phase II study of epirubicin/cyclophosphamide followed by docetaxel and concurrent trastuzumab as primary systemic therapy for HER-2 positive advanced breast cancer (the HER2NAT study)

International Journal of Clinical Oncology ◽

10.1007/s10147-012-0437-1 ◽

2012 ◽

Vol 18 (4) ◽

pp. 598-606 ◽

Cited By ~ 3

Author(s):

Kenjiro Aogi ◽

Toshiaki Saeki ◽

Seigo Nakamura ◽

Masahiro Kashiwaba ◽

Nobuaki Sato ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Systemic Therapy ◽

Phase Ii Study ◽

Advanced Breast ◽

Primary Systemic Therapy ◽

Multicenter Phase ◽

Her 2

Download Full-text

Metronomic oral chemotherapy with cyclophosphamide plus capecitabine combined with trastuzumab (HEX) as first line therapy of HER-2 positive advanced breast cancer: A phase II trial of the Gruppo Oncologico Italia Meridionale (GOIM)

The Breast ◽

10.1016/j.breast.2020.06.002 ◽

2020 ◽

Vol 53 ◽

pp. 18-22 ◽

Cited By ~ 1

Author(s):

Laura Orlando ◽

Vito Lorusso ◽

Francesco Giotta ◽

Massimo Di Maio ◽

Paola Schiavone ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Oral Chemotherapy ◽

Advanced Breast ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Her 2

Download Full-text

Abstract P1-19-40: Apatinib in the treatment of HER-2 negative advanced breast cancer with chest wall metastasis multicenter phase II clinical study

10.1158/1538-7445.sabcs19-p1-19-40 ◽

2020 ◽

Author(s):

Huiping Li ◽

Cuizhi Geng ◽

Guohong Song ◽

Hanfang Jiang ◽

Zhongshen Tong ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Study ◽

Advanced Breast Cancer ◽

Chest Wall ◽

Phase Ii ◽

Advanced Breast ◽

Multicenter Phase ◽

Phase Ii Clinical Study ◽

Her 2

Download Full-text

Abstract OT1-01-02: A multicenter phase II trial to evaluate the efficacy and safety of pembrolizumab and gemcitabine in patients with HER2-negative advanced breast cancer: GEICAM/2015-04 PANGEA-Breast

10.1158/1538-7445.sabcs17-ot1-01-02 ◽

2018 ◽

Author(s):

L de la Cruz ◽

V Sánchez-Margalet ◽

P Berraondo ◽

S Benito ◽

MJ Escudero ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Breast ◽

Efficacy And Safety ◽

Multicenter Phase

Download Full-text

Multicenter phase II trial of gemcitabine plus liposomal doxorubicin in chemotherapeutically pretreated patients with advanced breast cancer (ABC

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.696 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 696-696

Author(s):

K. Haider ◽

G. Kornek ◽

W. Kwasny ◽

D. Depisch ◽

T. Payrits ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Advanced Breast ◽

Multicenter Phase ◽

Pretreated Patients

Download Full-text